CNBX Pharmaceuticals Inc. (CNBX)

CIK 1343009 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for CNBX Pharmaceuticals Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001753926-26-001524
Jun 24, 202610-Q0001683168-26-005078
May 8, 2026SCHEDULE 13G/A0001753926-26-000803
Apr 14, 202610-Q0001683168-26-002899
Mar 17, 20268-K0001683168-26-001883
Feb 5, 2026SCHEDULE 13G/A0001753926-26-000272
Jan 14, 202610-Q0001683168-26-000285
Dec 1, 202510-K0001683168-25-008736
Aug 13, 2025SCHEDULE 13G/A0001753926-25-001322
Jul 14, 202510-Q0001683168-25-005075
May 13, 2025SCHEDULE 13G/A0001753926-25-000800
Apr 14, 202510-Q0001683168-25-002511
Feb 13, 2025SCHEDULE 13G/A0001753926-25-000250
Jan 30, 20258-K0001683168-25-000583
Jan 13, 202510-Q0001683168-25-000267
Nov 29, 202410-K0001683168-24-008433
Nov 14, 2024SC 13G/A0001753926-24-001918
Jul 15, 202410-Q0001683168-24-004831
Apr 16, 202410-Q0001683168-24-002440
Apr 15, 2024NT 10-Q0001683168-24-002385
Mar 22, 20248-K0001683168-24-001610
Feb 13, 2024SC 13G/A0001753926-24-000285
Jan 12, 202410-Q0001683168-24-000255
Nov 30, 202310-K0001683168-23-008557
Jul 14, 202310-Q0001683168-23-004890